NYSE:BAX Baxter International (BAX) Stock Price, News & Analysis $36.32 +1.24 (+3.53%) (As of 10/4/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends About Baxter International Stock (NYSE:BAX) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Baxter International alerts:Sign Up Key Stats Today's Range$34.94▼$36.3750-Day Range$34.51▼$40.2652-Week Range$31.01▼$44.01Volume5.15 million shsAverage Volume4.16 million shsMarket Capitalization$18.51 billionP/E Ratio6.98Dividend Yield3.19%Price Target$42.00Consensus RatingHold Company OverviewBaxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.Read More… Next opportunity for crypto millions (Ad)October isn't just another month in crypto. It's the launchpad for what could be the most explosive bull run in history. And I've found the rocket fuel… One coin is quietly positioning itself to outperform the entire market. The signs are everywhere…Go here to discover the coin that could define this historic bull run with gains kicking off this mo Baxter International Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks96th Percentile Overall ScoreBAX MarketRank™: Baxter International scored higher than 96% of companies evaluated by MarketBeat, and ranked 60th out of 994 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.0 / 5Analyst RatingHold Consensus RatingBaxter International has received a consensus rating of Hold. The company's average rating score is 2.09, and is based on 2 buy ratings, 8 hold ratings, and 1 sell rating.Amount of Analyst CoverageBaxter International has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Baxter International's stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth8.11% Earnings GrowthEarnings for Baxter International are expected to grow by 8.11% in the coming year, from $2.96 to $3.20 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Baxter International is 6.98, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 118.41.Price to Earnings Ratio vs. SectorThe P/E ratio of Baxter International is 6.98, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 109.58.Price to Earnings Growth RatioBaxter International has a PEG Ratio of 1.32. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioBaxter International has a P/B Ratio of 2.18. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Baxter International's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.59% of the outstanding shares of Baxter International have been sold short.Short Interest Ratio / Days to CoverBaxter International has a short interest ratio ("days to cover") of 3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Baxter International has recently increased by 21.21%, indicating that investor sentiment is decreasing significantly. Dividend2.5 / 5Dividend StrengthModerate Dividend YieldBaxter International pays a meaningful dividend of 3.14%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthBaxter International does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Baxter International is 22.31%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Baxter International will have a dividend payout ratio of 36.25% next year. This indicates that Baxter International will be able to sustain or increase its dividend.Read more about Baxter International's dividend. Sustainability and ESG4.0 / 5Environmental Score-1.95 Percentage of Shares Shorted2.59% of the outstanding shares of Baxter International have been sold short.Short Interest Ratio / Days to CoverBaxter International has a short interest ratio ("days to cover") of 3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Baxter International has recently increased by 21.21%, indicating that investor sentiment is decreasing significantly. News and Social Media1.9 / 5News Sentiment0.38 News SentimentBaxter International has a news sentiment score of 0.38. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.54 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 12 news articles for Baxter International this week, compared to 8 articles on an average week.Search InterestOnly 14 people have searched for BAX on MarketBeat in the last 30 days. This is a decrease of -56% compared to the previous 30 days.MarketBeat FollowsOnly 3 people have added Baxter International to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Baxter International insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.21% of the stock of Baxter International is held by insiders.Percentage Held by Institutions90.19% of the stock of Baxter International is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Baxter International's insider trading history. Receive BAX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Baxter International and its competitors with MarketBeat's FREE daily newsletter. Email Address BAX Stock News HeadlinesHelene damaged a factory that makes IV fluidsOctober 5 at 1:37 PM | msn.comSupply chain issues hit hospitals, dialysis centers following Hurricane HeleneOctober 3 at 1:45 PM | msn.comNext opportunity for crypto millionsThe floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since they first opened to investors. Wall Street is finally embracing crypto. But most investors are missing the real goldmine… October 6, 2024 | Crypto 101 Media (Ad)Hurricane-driven IV fluid shortage hits MGBOctober 3 at 1:45 PM | bizjournals.comBaxter International (NYSE:BAX) Shares Gap Down to $38.91October 2, 2024 | americanbankingnews.comCitigroup Increases Baxter International (NYSE:BAX) Price Target to $40.00October 2, 2024 | americanbankingnews.comBaxter International (NYSE:BAX) Lowered to "Hold" at StockNews.comOctober 1, 2024 | americanbankingnews.comSupply chain issues hit hospitals, dialysis centers after Hurricane HeleneOctober 1, 2024 | msn.comSee More Headlines BAX Stock Analysis - Frequently Asked Questions How have BAX shares performed this year? Baxter International's stock was trading at $38.66 at the beginning of 2024. Since then, BAX stock has decreased by 6.1% and is now trading at $36.32. View the best growth stocks for 2024 here. How were Baxter International's earnings last quarter? Baxter International Inc. (NYSE:BAX) released its earnings results on Tuesday, August, 6th. The medical instruments supplier reported $0.68 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.66 by $0.02. The company's revenue was up 2.8% compared to the same quarter last year. Read the conference call transcript. Does Baxter International have any subsidiaries? Baxter International subsidiaries include these companies: Cheetah Medical, ApaTech Limited, Baxter AO, Baxter Belgium SPRL, Baxter (China) Investment Co. Ltd, Baxter Company Ltd, Baxter Corporation (Canada), and more. Who are Baxter International's major shareholders? Baxter International's top institutional shareholders include Handelsbanken Fonder AB (0.04%), Trust Co. of Toledo NA OH, Neville Rodie & Shaw Inc. and SG Americas Securities LLC. Insiders that own company stock include Jeanne K Mason, Albert P L Stroucken, Jacqueline Kunzler and Brian Stevens. View institutional ownership trends. How do I buy shares of Baxter International? Shares of BAX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Baxter International own? Based on aggregate information from My MarketBeat watchlists, some other companies that Baxter International investors own include Xtrackers California Municipal Bond ETF (CA), Johnson & Johnson (JNJ), Pfizer (PFE), Cisco Systems (CSCO), Intel (INTC) and Abbott Laboratories (ABT). Company Calendar Last Earnings8/06/2024Ex-Dividend for 10/1 Dividend8/30/2024Dividend Payable10/01/2024Today10/06/2024Next Earnings (Estimated)11/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical & medical instruments Sub-IndustryHealth Care Equipment Current SymbolNYSE:BAX CUSIP07181310 CIK10456 Webwww.baxter.com Phone(224) 948-2000Fax224-948-1813Employees60,000Year Founded1931Price Target and Rating Average Stock Price Target$42.00 High Stock Price Target$54.00 Low Stock Price Target$30.00 Potential Upside/Downside+15.6%Consensus RatingHold Rating Score (0-4)2.09 Research Coverage11 Analysts Profitability EPS (Most Recent Fiscal Year)$5.20 Trailing P/E Ratio6.98 Forward P/E Ratio12.27 P/E Growth1.32Net Income$2.66 billion Net Margins16.51% Pretax Margin-0.50% Return on Equity18.06% Return on Assets5.21% Debt Debt-to-Equity Ratio1.35 Current Ratio1.40 Quick Ratio0.91 Sales & Book Value Annual Sales$15.00 billion Price / Sales1.23 Cash Flow$4.88 per share Price / Cash Flow7.44 Book Value$16.69 per share Price / Book2.18Miscellaneous Outstanding Shares509,580,000Free Float508,510,000Market Cap$18.51 billion OptionableOptionable Beta0.59 Social Links The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report This page (NYSE:BAX) was last updated on 10/6/2024 by MarketBeat.com Staff From Our PartnersWar on Elon Escalates… Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adopti...Porter & Company | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored320 hedge funds just sold this stock320 hedge funds just sold this stock A strange force has seized control of Wall Street. Hedge funds are alr...Chaikin Analytics | SponsoredHow much money are you leaving on the table from the stocks you already own?Charles Payne here, and I want to let you in on a time-tested trading method that can be used to generate cash...Unstoppable Prosperity | SponsoredGolden Equation: Volatility = OpportunityWhen the market swings wildly, most investors panic… But it doesn't have to be this way. You see, when t...Prosper Trading Academy | SponsoredAI Expert Reveals New PickEveryone’s talking about AI right now, but I’ve been talking about it for years. And now I’ve just released...Brownstone Research | SponsoredGold at $2,600... But This Stock Gives You More for Under $20Gold just soared over $2,600 an ounce. But what if I told you there's a way to get exposure to MORE than an...Monument Traders Alliance | SponsoredNext opportunity for crypto millionsAll the Pieces Falling into Place for Crypto… Unlock the Potential of the 2024 Crypto Bull Run!Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Baxter International Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Baxter International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.